We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.21B
AUM Growth
-$1.88M
Cap. Flow
-$98.4M
Cap. Flow %
-8.16%
Top 10 Hldgs %
29.75%
Holding
126
New
13
Increased
20
Reduced
44
Closed
13

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$17.9M
2
VLO icon
Valero Energy
VLO
+$16.7M
3
ADI icon
Analog Devices
ADI
+$16.4M
4
MRK icon
Merck
MRK
+$16M
5
CVX icon
Chevron
CVX
+$15.3M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$25.9M
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$18.1M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$15.9M
4
DHR icon
Danaher
DHR
+$15.6M
5
HCA icon
HCA Healthcare
HCA
+$15.5M

Sector Composition

Rank Sector Weight
1 Financials 19.47%
2 Technology 14.69%
3 Healthcare 11.02%
4 Industrials 9.65%
5 Communication Services 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GS icon
76
Goldman Sachs
GS
$313B
$1M 0.08%
1,260
– –
CRM icon
77
Salesforce
CRM
$134B
$972K 0.08%
4,100
+700
+21% +$177K
NUE icon
78
Nucor
NUE
$56.4B
$962K 0.08%
+7,100
New +$1.01M
AMT icon
79
American Tower
AMT
$77.7B
$904K 0.08%
4,700
-30,400
-87% -$6.33M
SUSC icon
80
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
$838K 0.07%
35,557
– –
HD icon
81
Home Depot
HD
$332B
$717K 0.06%
1,770
– –
DE icon
82
Deere & Co
DE
$170B
$594K 0.05%
+1,300
New +$641K
TFC icon
83
Truist Financial
TFC
$63.2B
$585K 0.05%
12,800
– –
QCOM icon
84
Qualcomm
QCOM
$176B
$532K 0.04%
3,200
– –
EMR icon
85
Emerson Electric
EMR
$82.9B
$459K 0.04%
3,500
-10,000
-74% -$1.36M
DOV icon
86
Dover
DOV
$27.2B
$447K 0.04%
2,680
– –
XOM icon
87
ExxonMobil
XOM
$651B
$417K 0.03%
3,700
-232,800
-98% -$25.9M
RSG icon
88
Republic Services
RSG
$66.7B
$413K 0.03%
1,800
– –
DHR icon
89
Danaher
DHR
$135B
$397K 0.03%
2,000
-78,600
-98% -$15.6M
LMT icon
90
Lockheed Martin
LMT
$134B
$369K 0.03%
740
-23,600
-97% -$10.7M
AMAT icon
91
Applied Materials
AMAT
$426B
$328K 0.03%
1,600
– –
MA icon
92
Mastercard
MA
$477B
$319K 0.03%
560
– –
MCHP icon
93
Microchip Technology
MCHP
$42.8B
$308K 0.03%
4,800
– –
MDLZ icon
94
Mondelez International
MDLZ
$77.7B
$285K 0.02%
4,570
-109,700
-96% -$7.08M
AEP icon
95
American Electric Power
AEP
$73.7B
$281K 0.02%
2,500
– –
EQT icon
96
EQT Corp
EQT
$33.2B
$272K 0.02%
5,000
– –
WM icon
97
Waste Management
WM
$95.9B
$265K 0.02%
1,200
– –
DIS icon
98
Walt Disney
DIS
$165B
$232K 0.02%
2,030
– –
VST icon
99
Vistra
VST
$55.1B
$216K 0.02%
1,100
– –
PSA icon
100
Public Storage
PSA
$60.2B
$214K 0.02%
740
– –
1 2 3
4
5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q3 2025 Portfolio in Review

As of Q3 2025, Payden & Rygel held 126 positions worth $1.21B, down 0.16% from $1.21B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Payden & Rygel withdrew a net $98.4M in Q3 2025, closing 13 positions and reducing 44 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Payden & Rygel opened a new position in CVS Health worth $19.7M.

  • Payden & Rygel's largest Q3 2025 buy was CVS Health: 261,500 shares worth $19.7M.
  • Payden & Rygel added most to Merck in Q3 2025, an estimated $16M increase.
  • Payden & Rygel's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $25.9M.
  • Payden & Rygel fully exited Berkshire Hathaway Class B in Q3 2025, selling an estimated $15.9M.
  • Payden & Rygel's ten largest holdings make up 30% of its $1.21B portfolio in Q3 2025.
  • Payden & Rygel opened 13 new positions and closed 13 in Q3 2025.
  • Payden & Rygel's portfolio value fell 0.16% quarter-over-quarter to $1.21B.

Based on Payden & Rygel's 13F filing for Q3 2025, filed 10 Nov 2025.